Oncology & Cancer

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at the annual meeting of ...

Oncology & Cancer

Personalized blood test can detect persistent lung cancer

Patients who are at a higher risk of their lung cancer returning can be identified by a personalized blood test that is performed after treatment, according to researchers at the University of Cambridge.

Oncology & Cancer

Could a pap test help detect breast, ovarian cancers, too?

Pap tests have long been used to detect cervical cancer early, but preliminary research suggests that cervical cells collected during those tests could also be used to catch other cancers, including deadly ovarian tumors.

page 3 from 26